News from mei pharma, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 04, 2015, 09:00 ET

MEI Pharma to Present at Wedbush PacGrow Healthcare Conference

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Jul 01, 2015, 09:00 ET

MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Jun 12, 2015, 08:00 ET

MEI Pharma Reports Updated Results from Phase II Study of Pracinostat and Azacitidine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced updated...

May 06, 2015, 09:00 ET

MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

May 04, 2015, 09:00 ET

MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced new...

Apr 01, 2015, 09:00 ET

MEI Pharma to Present at Needham Healthcare Conference

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel...

Mar 23, 2015, 07:00 ET
MEI Pharma Logo.

MEI Pharma Announces Top-Line Data From Randomized Phase II Clinical Study Of Pracinostat In Front-Line Myelodysplastic Syndrome

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced...

Feb 26, 2015, 09:00 ET
MEI Pharma Logo

MEI Pharma to Present at Cowen and Company Health Care Conference

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Dec 22, 2014, 09:00 ET
MEI Pharma Logo.

MEI Pharma Reaches Response Milestone in Phase II Clinical Trial of Pracinostat in Refractory Myelodysplastic Syndrome

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced that...

Dec 17, 2014, 16:05 ET
MEI Pharma Logo.

MEI Pharma Completes Public Offering of Common Stock

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Dec 12, 2014, 08:00 ET
MEI Pharma Logo.

MEI Pharma Announces Pricing Of Public Offering Of Common Stock

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Dec 10, 2014, 16:01 ET

MEI Pharma Announces $45 Million Proposed Public Offering of Common Stock

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Dec 08, 2014, 08:30 ET
MEI Pharma Logo.

MEI Pharma Reports Significant Clinical Activity In Phase II Study Of Pracinostat In Front Line Acute Myeloid Leukemia

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, reported significant...

Dec 04, 2014, 06:00 ET
MEI Pharma Logo

MEI Pharma Announces Election of Pharmaceutical Industry Veteran Kevan Clemens to Board of Directors

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced the election...

Dec 02, 2014, 08:30 ET
MEI Pharma Logo.

MEI Pharma Completes Enrollment in Phase II Study of Pracinostat in Front Line Acute Myeloid Leukemia

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Dec 01, 2014, 09:00 ET
MEI Pharma Logo

MEI Pharma To Host Analyst And Investor Event

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, will host its 2nd...

Nov 26, 2014, 09:00 ET
MEI Pharma Logo.

MEI Pharma To Host Annual Meeting Of Stockholders

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, will host its Annual...

Nov 12, 2014, 09:00 ET
MEI Pharma Logo.

MEI Pharma to Present at Stifel Healthcare Conference

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel...

Nov 06, 2014, 09:01 ET

MEI Pharma Reports Improved Response Rates in Phase II Study of Pracinostat in Front Line Acute Myeloid Leukemia

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced that data...

Oct 29, 2014, 08:30 ET
MEI Pharma Logo.

MEI Pharma Advances Clinical Study Of Mitochondrial Inhibitor ME-344 In Small Cell Lung And Ovarian Cancers

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that the...